Invention Grant
- Patent Title: Amylin analogues
-
Application No.: US15074526Application Date: 2016-03-18
-
Publication No.: US10766939B2Publication Date: 2020-09-08
- Inventor: Rasmus Just , Oliver Demmer , Lise Giehm , Jesper Sloth Villadsen , Henrik Munch , Jesper Mosolff Mathiesen , Jolanta Skarbaliene , Maria Deryabina , Dieter Wolfgang Hamprecht
- Applicant: Zealand Pharma A/S
- Applicant Address: DK Søborg
- Assignee: Zealand Pharma A/S
- Current Assignee: Zealand Pharma A/S
- Current Assignee Address: DK Søborg
- Agency: Clark & Elbing LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@7083d269
- Main IPC: C07K14/575
- IPC: C07K14/575 ; C07K14/47 ; A61K38/00
Abstract:
The present invention relates to amylin analogs and to their use in the treatment or prevention of a variety of diseases, conditions or disorders, including obesity, excess food intake and associated metabolic diseases such as diabetes. The analogs have good physical and chemical stability, good solubility, and a long duration of action, and are well suited for use in the form of a liquid formulation.
Public/Granted literature
- US20160272693A1 AMYLIN ANALOGUES Public/Granted day:2016-09-22
Information query
